Last reviewed · How we verify
NCT05118373
Generic Behavioural Change Campaign for COVID-19 Prevention
NA trial testing BEHAVIOURAL CHANGE CAMPAIGN FOR COVID-19 PREVENTION IN ZAMBIA in Evaluation Study in 2,004 participants. Completed in 23 September 2021.
23 September 2021
Quick facts
| Lead sponsor | Centre for Infectious Disease Research in Zambia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 2,004 |
| Start date | 18 August 2021 |
| Primary completion | 23 September 2021 |
| Estimated completion | 23 September 2021 |
| Sites | 1 location across Zambia |
Drugs / interventions tested
- BEHAVIOURAL CHANGE CAMPAIGN FOR COVID-19 PREVENTION IN ZAMBIA
Conditions studied
- Evaluation Study — all drugs for Evaluation Study →
Sponsor
Centre for Infectious Disease Research in Zambia — full company profile →
Who can join
18 and older, any sex, with Evaluation Study. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Since the start of the COVID-19 pandemic in Zambia, multiple information, education and communication (IEC) materials and strategies have been disseminated by national risk communication and community engagement (RCCE) committees to create awareness on the facts of the novel coronavirus, prevention measures and care-seeking options. To complement these efforts in Zambia, CIDRZ in collaboration with the London School of Hygiene and Tropical Medicine (LSHTM) are implementing an internationally produced communication campaign that promotes the uptake of four key behaviours to reduce the transmission of COVID-19, namely, hand washing with soap, mask wearing, social distancing and surface cleaning. The campaign presents these behaviours as a 'password' that should be enacted to get lives back to normal and was created by the Hygiene Behaviour Change Coalition (HBCC). The idea of a password has been used to symbolize access into a world where protective habits are practiced in order to get back a world that is corona free. The password in this case is Hands-Face-Space-Surface. This campaign is a mass media campaign that will be delivered through TV, radio and billboards. This study aims to evaluate the process and effect of the HBCC campaign on the uptake of COVID-19 preventative behaviours among people living in Lusaka and Copperbelt Provinces of Zambia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05118373
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre for Infectious Disease Research in Zambia trials
Trials by the same sponsor.
- NCT07107516 — Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers · Phase 1 · not yet recruiting
- NCT06903143 — Piloting a Biomarker-augmented Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) Program Among HI · NA · not yet recruiting
- NCT06503666 — Zambian Informed Motivated Aware Responsible Adolescent Girls and Adults · NA · recruiting
- NCT07021092 — PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY · NA · recruiting
- NCT06904521 — OH Baseline Research Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05118373 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre for Infectious Disease Research in Zambia
- Last refreshed: 12 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05118373.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing